Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in J Clin Virol Retrieve available abstracts of 16 articles: HTML format

Single Articles

April 2024
1. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
   Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
   J Clin Virol. 2024;171:105657.
   PubMed     Abstract available
   
   
   
2. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
   Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
   J Clin Virol. 2024;171:105649.
   PubMed     Abstract available
   
   
   February 2024
3. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
   Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
   J Clin Virol. 2024;171:105660.
   PubMed    
   
   
   January 2024
4. OSTRBENK VALENCAK A, Cuschieri K, Connor L, Zore A, et al
   Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
   J Clin Virol. 2024;170:105638.
   PubMed     Abstract available
   
   
   September 2023
5. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
   First international proficiency study on human papillomavirus testing in cervical cancer screening.
   J Clin Virol. 2023;167:105581.
   PubMed     Abstract available
   
   
   July 2023
6. ELASIFER H, Amukwaya MMN, Bhatia R, Cuschieri K, et al
   The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
   J Clin Virol. 2023;164:105469.
   PubMed     Abstract available
   
   
   March 2023
7. MONTERO-MACIAS R, Veyer D, Bruneau T, Robillard N, et al
   TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion.
   J Clin Virol. 2023;161:105418.
   PubMed     Abstract available
   
   
   February 2023
8. GARLAND SM, Iftner T, Cuschieri K, Kaufmann AM, et al
   IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
   J Clin Virol. 2023;159:105349.
   PubMed     Abstract available
   
   
   October 2022
9. VAN KEER S, Latsuzbaia A, Vanden Broeck D, De Sutter P, et al
   Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.
   J Clin Virol. 2022;155:105271.
   PubMed     Abstract available
   
   
   July 2022
10. ARROYO MUHR LS, Eklund C, Lagheden C, Forslund O, et al
    Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
    J Clin Virol. 2022;154:105237.
    PubMed     Abstract available
    
    
    June 2022
11. BHATIA R, Graham C, Elasifer H, Asodaria P, et al
    Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.
    J Clin Virol. 2022;150-151:105165.
    PubMed     Abstract available
    
    
    December 2021
12. RAINE-BENNETT T, Gage JC, Poitras N, Chandra M, et al
    Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).
    J Clin Virol. 2021;145:105014.
    PubMed     Abstract available
    
    
    
13. JOSEPH J, Mangwendeza P, Maparo T, Mhizha T, et al
    Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
    J Clin Virol. 2021;145:105017.
    PubMed     Abstract available
    
    
    August 2021
14. EKLUND C, Muhr LSA, Lagheden C, Forslund O, et al
    The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
    J Clin Virol. 2021;141:104902.
    PubMed     Abstract available
    
    
    July 2021
15. OSTRBENK VALENCAK A, Bertram A, Groning A, Poljak M, et al
    Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.
    J Clin Virol. 2021;140:104851.
    PubMed     Abstract available
    
    
    April 2021
16. CUSCHIERI K, Wilson A, Palmer T, Stanczuk G, et al
    The challenges of defining sample adequacy in an era of HPV based cervical screening.
    J Clin Virol. 2021;137:104756.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.